ROCHESTER MEDICAL ULTRAFLEX CATHETER SALES CAN CONTINUE
This article was originally published in The Gray Sheet
Executive SummaryROCHESTER MEDICAL ULTRAFLEX CATHETER SALES CAN CONTINUE under a ruling in arbitration proceedings between Rochester and Mentor. According to Rochester, an American Arbitration Association panel rejected Mentor's claim that Rochester's sales of the Ultraflex self-adhering male external catheter (MEC) constitute a breach of an April 1991 licensing agreement between the two firms.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.